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Abstract
© 2017 Kuznetsova, Trofimov, Shubina, Kochetkova, Karetnikova, Barkov, Bakharev, Gusev and
Sukhikh.  Ataxia-telangiectasia  (A-T),  or  Louis-Bar  syndrome,  is  a  rare  neurodegenerative
disorder associated with immunodeficiency. For families with at least one affected child, timely
A-T genotyping during any subsequent pregnancy allows the parents to make an informed
decision about whether to continue to term when the fetus is affected. Mutations in the ATM
gene, which is 150 kb long, give rise to A-T; more than 600 pathogenic variants in ATM have
been  characterized  since  1990  and  new  mutations  continue  to  be  discovered  annually.
Therefore, limiting genetic screening to previously known SNPs by PCR or hybridization with
microarrays may not identify the specific pathog enic genotype in ATM for a given A-T family.
However, recent developments in next-generation sequencing technology offer prompt high-
throughput  full-length  sequencing  of  genomic  fragments  of  interest.  This  allows  the
identification of the whole spectrum of mutations in a gene, including any novel ones. We report
two  A-T  families  with  affected  children  and  current  pregnancies.  Both  families  are
consanguineous and originate from Caucasian regions of Russia and Azerbaijan. Before our
study, no ATM mutations had been identified in the older children of these families. We used ion
semiconductor sequencing and an Ion AmpliSeq ™ Inherited Disease Panel to perform complete
ATM gene sequencing in a single member of each family. Then we compared the experimentally
determined genotype with the affected/normal phenotype distribution in the whole family to
provide unambiguous evidence of pathogenic mutations responsible for A-T. A single novel SNP
was allocated to each family. In the first case, we found a mononucleotide deletion, and in the
second,  a mononucleotide insertion.  Both mutations lead to truncation of  the ATM protein
product. Identification of the pathogenic mutation in each family was performed in a timely
fashion, allowing the fetuses to be tested and diagnosed. The parents chose to continue with
both pregnancies as both fetuses had a healthy genotype and thus were not at risk of A-T.
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